Your browser doesn't support javascript.
loading
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials.
Denkert, Carsten; Seither, Fenja; Schneeweiss, Andreas; Link, Theresa; Blohmer, Jens-Uwe; Just, Marianne; Wimberger, Pauline; Forberger, Almuth; Tesch, Hans; Jackisch, Christian; Schmatloch, Sabine; Reinisch, Mattea; Solomayer, Erich F; Schmitt, Wolfgang D; Hanusch, Claus; Fasching, Peter A; Lübbe, Kristina; Solbach, Christine; Huober, Jens; Rhiem, Kerstin; Marmé, Frederik; Reimer, Toralf; Schmidt, Marcus; Sinn, Bruno V; Janni, Wolfgang; Stickeler, Elmar; Michel, Laura; Stötzer, Oliver; Hahnen, Eric; Furlanetto, Jenny; Seiler, Sabine; Nekljudova, Valentina; Untch, Michael; Loibl, Sibylle.
Afiliação
  • Denkert C; Institute of Pathology, Philipps-Universität Marburg and University Hospital of Giessen and Marburg, Marburg, Germany; German Breast Group, Neu-Isenburg, Germany. Electronic address: carsten.denkert@uni-marburg.de.
  • Seither F; German Breast Group, Neu-Isenburg, Germany.
  • Schneeweiss A; Nationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Link T; Department of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.
  • Blohmer JU; Breast Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Just M; Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, Germany.
  • Wimberger P; Department of Gynecology and Obstetrics, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.
  • Forberger A; Institut für Pathologie, Universitätsklinikum Carl Gustav Carus Dresden, Technische Universität Dresden, Dresden, Germany.
  • Tesch H; Onkologie Bethanien Krankenhaus Frankfurt, Frankfurt, Germany.
  • Jackisch C; Department of Gynecology, Sana Klinikum Offenbach, Offenbach, Germany.
  • Schmatloch S; Brustzentrum Kassel, Elisabeth Krankenhaus, Kassel, Germany.
  • Reinisch M; Interdisciplinary Breast Unit, Kliniken Essen Mitte, Essen, Germany.
  • Solomayer EF; Department of Gynecology, University of Saarland, Homburg, Germany.
  • Schmitt WD; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Berlin, Germany.
  • Hanusch C; Frauenklinik München, Rotkreuzklinikum München, München, Germany.
  • Fasching PA; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Lübbe K; DIAKOVERE Henriettenstift Gynäkologie, Hannover, Germany.
  • Solbach C; Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany.
  • Huober J; Department of Gynecology and Obstetrics, University Hospital Frankfurt, Frankfurt, Germany.
  • Rhiem K; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Marmé F; Medizinische Fakultät Mannheim, Universität Heidelberg, Universitätsfrauenklinik Mannheim, Germany.
  • Reimer T; Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany.
  • Schmidt M; Department of Obstetrics and Gynecology, Universitätsmedizin Mainz, Mainz, Germany.
  • Sinn BV; Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Pathology, Berlin, Germany.
  • Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, University of Ulm, Ulm, Germany.
  • Stickeler E; Clinics for Gynaecology and Obstetrica, Rheinisch-Westfälische Technische Hochschule Aachen University, Aachen, Germany.
  • Michel L; Nationales Centrum für Tumorerkrankungen, Universitätsklinikum und Deutsches Krebsforschungszentrum, Heidelberg, Germany.
  • Stötzer O; Hämatoonkologische Schwerpunktpraxis, München, Germany.
  • Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Furlanetto J; German Breast Group, Neu-Isenburg, Germany.
  • Seiler S; German Breast Group, Neu-Isenburg, Germany.
  • Nekljudova V; German Breast Group, Neu-Isenburg, Germany.
  • Untch M; Breast Cancer Center, Department of Gynecology and Obstetrics, Helios-Klinikum Berlin Buch, Germany.
  • Loibl S; German Breast Group, Neu-Isenburg, Germany; Goethe University of Frankfurt, Frankfurt, Germany.
Lancet Oncol ; 22(8): 1151-1161, 2021 08.
Article em En | MEDLINE | ID: mdl-34252375
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article